Espen Ajo Arnevik

  • Clinical psychologist; PhD

Leader for Section for clinical addiction research (www.rusforsk.no).

Affiliations:

1. Section for clinical addiction research, Department of mental health and addiction treatment, Oslo University Hospital
2. Department of psychology, University of Oslo

Research interests:

Clinical addiction research, treatment effect, psychotherapy research, personality disorder treatment

Relevant links:

Rusforsk research projects

Espen Ajo Arnevik - Google Scholar

Espen Ajo Arnevik - Orcid

 

Publications 2024

Høiland K, Arnevik EA, Egeland J (2024)
Alcohol use disorder and fitness to drive: Discrepancies between health professionals’ evaluations and objective measures of alcohol use and cognitive functioning
Nordic Studies on Alcohol and Drugs, 0, 1-13
DOI 10.1177/1455072523121997, PublikaID 481

Publications 2022

Kvarstein EH, Zahl KE, Stanicke LI, Pettersen MS, Baltzersen AL, Johansen MS, Eikenaes IUM, Arnevik EA, Hummelen B, Wilberg T, Pedersen G (2022)
Vulnerability of personality disorder during the Covid-19 crises - a multicenter survey of treatment experiences among patients referred to treatment
Nord. J. Psychiatr., 76 (1), 52-63
DOI 10.1080/08039488.2021.1934110

Publications 2021

Baekkelund H, Karlsrud I, Hoffart A, Arnevik EA (2021)
Stabilizing group treatment for childhood-abuse related PTSD: a randomized controlled trial
Eur. J. Psychotraumatol., 12 (1), 1859079
DOI 10.1080/20008198.2020.1859079

Kvarstein EH, Zahl KE, Stanicke LI, Pettersen MS, Baltzersen AL, Johansen MS, Eikenaes IUM, Hummelen B, Wilberg T, Arnevik EA, Pedersen G (2021)
Vulnerability of personality disorder during COVID-19 crises: a multicenter survey of mental and social distress among patients referred to treatment
Nord. J. Psychiatr.
DOI 10.1080/08039488.2021.1942980

Paap MCS, Hummelen B, Braeken J, Arnevik EA, Walderhaug E, Wilberg T, Berghuis H, Hutsebaut J, Pedersen G (2021)
A multi-center psychometric evaluation of the Severity Indices of Personality Problems 118 (SIPP-118): Do we really need all those facets?
Qual. Life Res., 30 (2), 567-575
DOI 10.1007/s11136-020-02654-8

Rognli EB, Aas EM, Drake RE, Marsden J, Anders P, Bond GR, Lystad JU, Reme SE, Arnevik EA (2021)
The effect evaluation of Individual Placement and Support (IPS) for patients with substance use disorders: study protocol for a randomized controlled trial of IPS versus enhanced self-help
Trials, 22 (1), 705
DOI 10.1186/s13063-021-05673-z

Tonga JB, Benth JS, Arnevik EA, Werheid K, Korsnes MS, Ulstein ID (2021)
Managing depressive symptoms in people with mild cognitive impairment and mild dementia with a multicomponent psychotherapy intervention: a randomized controlled trial
Int. Psychogeriatr., 33 (3), PII S1041610220000216-231
DOI 10.1017/S1041610220000216

Publications 2020

Brorson HH, Arnevik EA, Rand-Hendriksen K, Duckert F (2020)
Drop-out from addiction treatment: A systematic review of risk factors (vol 33, pg 1010, 2020)
Clin. Psychol. Rev., 76, 101796
DOI 10.1016/j.cpr.2019.101796

Gatti F, Walderhaug E, Kern-Godal A, Lysell J, Arnevik EA (2020)
Complementary horse-assisted therapy for substance use disorders: a randomized controlled trial
Addict. Sci. Clin. Pract., 15 (1), 7
DOI 10.1186/s13722-020-0183-z

Rand K, Arnevik EA, Walderhaug E (2020)
Quality of life among patients seeking treatment for substance use disorder, as measured with the EQ-5D-3L
J. Patient-Rep. Outcomes, 4 (1), 92
DOI 10.1186/s41687-020-00247-0

Tonga JB, Eilertsen DE, Solem IKL, Arnevik EA, Korsnes MS, Ulstein ID (2020)
Effect of Self-Efficacy on Quality of Life in People With Mild Cognitive Impairment and Mild Dementia: The Mediating Roles of Depression and Anxiety
Am. J. Alzheimers Dis. Other Dement., 35, 1533317519885264
DOI 10.1177/1533317519885264

Publications 2019

Arnevik EA, Pedersen G, Walderhaug E, Lien I, Wilberg T, Hummelen B (2019)
Measuring Personality Problems in Patients With Substance Use Disorders: A Cross-Sample Validation
J. Dual Diagn., 15 (4), 324-332
DOI 10.1080/15504263.2019.1668583

Brorson HH, Arnevik EA, Rand K (2019)
Predicting Dropout from Inpatient Substance Use Disorder Treatment: A Prospective Validation Study of the OQ-Analyst
Subst. Abus.-Res. Treat., 13, 1178221819866181
DOI 10.1177/1178221819866181

Hagen E, Somhovd M, Hesse M, Arnevik EA, Erga AH (2019)
Measuring cognitive impairment in young adults with polysubstance use disorder with MoCA or BRIEF-A - The significance of psychiatric symptoms
J. Subst. Abus. Treat., 97, 21-27
DOI 10.1016/j.jsat.2018.11.010

Hauger LE, Sagoe D, Vaskinn A, Arnevik EA, Leknes S, Jorstad ML, Bjornebekk A (2019)
Anabolic androgenic steroid dependence is associated with impaired emotion recognition
Psychopharmacology, 236 (9), 2667-2676
DOI 10.1007/s00213-019-05239-7

Helverschou SB, Brunvold AR, Arnevik EA (2019)
Treating Patients With Co-occurring Autism Spectrum Disorder and Substance Use Disorder: A Clinical Explorative Study
Subst. Abus.-Res. Treat., 13, 1178221819843291
DOI 10.1177/1178221819843291

Pedersen G, Arnevik EA, Hummelen B, Walderhaug E, Wilberg T (2019)
Psychometric Properties of the Severity Indices of Personality Problems (SIPP) in Two Samples A Norwegian Community Sample and Clinical Samples of Patients With and Without Personality Disorders
Eur. J. Psychol. Assess., 35 (5), 698-711
DOI 10.1027/1015-5759/a000436

Somhovd M, Hagen E, Bergly T, Arnevik EA (2019)
The Montreal Cognitive Assessment as a predictor of dropout from residential substance use disorder treatment
Heliyon, 5 (3), e01282
DOI 10.1016/j.heliyon.2019.e01282

Publications 2018

Baekkelun H, Frewen P, Lanius R, Berg AO, Arnevik EA (2018)
Trauma-related altered states of consciousness in post-traumatic stress disorder patients with or without comorbid dissociative disorders
Eur. J. Psychotraumatol., 9 (1), 1544025
DOI 10.1080/20008198.2018.1544025

Nordheim K, Walderhaug E, Alstadius S, Kern-Godal A, Arnevik E, Duckert F (2018)
Young adults' reasons for dropout from residential substance use disorder treatment
Qual. Soc. Work, 17 (1), 24-40
DOI 10.1177/1473325016654559

Publications 2016

Arnevik EA, Helverschou SB (2016)
Autism Spectrum Disorder and Co-occurring Substance Use Disorder - A Systematic Review
Subst. Abus.-Res. Treat., 10, 69-75
DOI 10.4137/SART.S39921

Kern-Godal A, Brenna IH, Arnevik EA, Ravndal E (2016)
More Than Just a Break from Treatment: How Substance Use Disorder Patients Experience the Stable Environment in Horse-Assisted Therapy
Subst. Abus.-Res. Treat., 10, 99-108
DOI 10.4137/SART.S40475

Kern-Godal A, Brenna IH, Kogstad N, Arnevik EA, Ravndal E (2016)
Contribution of the patient-horse relationship to substance use disorder treatment: Patients' experiences
Int. J. Qual. Stud. Health Well-Being, 11, 31636
DOI 10.3402/qhw.v11.31636

Lien IA, Arnevik EA (2016)
Assessment of personality problems among patients with substance use disorders
Nord. Stud. Alcohol Drugs, 33 (4), 399-414
DOI 10.1515/nsad-2016-0033

Tonga JB, Arnevik EA, Werheid K, Ulstein ID (2016)
Manual-based cognitive behavioral and cognitive rehabilitation therapy for young-onset dementia: a case report
Int. Psychogeriatr., 28 (3), 519-522
DOI 10.1017/S1041610215001696

Tonga JB, Karlsoeen BB, Arnevik EA, Werheid K, Korsnes MS, Ulstein ID (2016)
Challenges With Manual-Based Multimodal Psychotherapy for People With Alzheimer's Disease: A Case Study
Am. J. Alzheimers Dis. Other Dement., 31 (4), 311-317
DOI 10.1177/1533317515603958

Publications 2015

Kern-Godal A, Arnevik EA, Walderhaug E, Ravndal E (2015)
Substance use disorder treatment retention and completion: a prospective study of horse-assisted therapy (HAT) for young adults
Addict. Sci. Clin. Pract., 10
DOI 10.1186/s13722-015-0043-4

Publications 2014

Amble I, Gude T, Stubdal S, Oktedalen T, Skjorten AM, Andersen BJ, Solbakken OA, Brorson HH, Arnevik E, Lambert MJ, Wampold BE (2014)
Psychometric properties of the Outcome Questionnaire-45.2: The Norwegian version in an international context
Psychother. Res., 24 (4), 504-513
DOI 10.1080/10503307.2013.849016

Publications 2013

Brorson HH, Arnevik EA, Rand-Hendriksen K, Duckert F (2013)
Drop-out from addiction treatment: A systematic review of risk factors
Clin. Psychol. Rev., 33 (8), 1010-1024
DOI 10.1016/j.cpr.2013.07.007

Kvarstein EH, Arnevik E, Halsteinli V, Ro FG, Karterud S, Wilberg T (2013)
Health service costs and clinical gains of psychotherapy for personality disorders: a randomized controlled trial of day-hospital-based step-down treatment versus outpatient treatment at a specialist practice
BMC Psychiatry, 13, 315
DOI 10.1186/1471-244X-13-315

Publications 2010

Arnevik E, Wilberg T, Urnes O, Johansen M, Monsen JT, Karterud S (2010)
PSYCHOTHERAPY FOR PERSONALITY DISORDERS: 18 MONTHS' FOLLOW-UP OF THE ULLEVAL PERSONALITY PROJECT
J. Pers. Disord., 24 (2), 188-203
DOI 10.1521/pedi.2010.24.2.188

Publications 2009

Arnevik E, Wilberg T, Monsen JT, Andrea H, Karterud S (2009)
A cross-national validity study of the Severity Indices of Personality Problems (SIPP-118)
Personal. Ment. Health, 3 (1), 41-55
DOI 10.1002/pmh.60

Arnevik E, Wilberg T, Urnes O, Johansen M, Monsen JT, Karterud S (2009)
Psychotherapy for personality disorders: Short-term day hospital psychotherapy versus outpatient individual therapy - a randomized controlled study
Eur. Psychiat., 24 (2), 71-78
DOI 10.1016/j.eurpsy.2008.09.004